Immix Biopharma (IMMX) Assets (2020 - 2026)
Immix Biopharma (IMMX) reported Assets of $239.11 million for Q2 2026, compared with $15.64 million a year earlier and up 149.5% from the prior quarter.
Powered by 
Analysis
Immix Biopharma (IMMX) Assets (2020 - 2026) Analysis & Trends
At the end of FY2025, Immix Biopharma posted Assets of $104.84 million, up 356.9% from FY2024.
- Assets has increased for three consecutive years, with a five-year compound annual growth rate of 186.9% (FY2020 to FY2025).
- By year, Assets came in at $22.95 million in FY2024 (+15.2%), $19.93 million in FY2023 (+33.7%), $14.91 million in FY2022 (-18.1%) and $18.19 million in FY2021.
- The Q2 2026 figure ranks as the highest quarterly Assets in data going back to Q4 2020.
- Year over year, Assets gained in four of the last seven quarters, with growth averaging 93.9%.
- The high point for year-over-year Assets in five years was Q1 2026 (growth of 381.7%); the low point was Q2 2025 (a decline of 45.8%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $95.82 million (Q1 2026), $104.84 million (Q4 2025) and $20.08 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Immix Biopharma | 820.51 Mn | 820.51 Mn | - | 239.11 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 239.11 Mn |
| Mar 31, 2026 | 95.82 Mn |
| Dec 31, 2025 | 104.84 Mn |
| Sep 30, 2025 | 20.08 Mn |
| Jun 30, 2025 | 15.64 Mn |
| Mar 31, 2025 | 19.89 Mn |
| Dec 31, 2024 | 22.95 Mn |
| Sep 30, 2024 | 25.14 Mn |
| Jun 30, 2024 | 28.84 Mn |
| Mar 31, 2024 | 34.35 Mn |
| Dec 31, 2023 | 19.93 Mn |
| Sep 30, 2023 | 22.47 Mn |
| Jun 30, 2023 | 15.57 Mn |
| Mar 31, 2023 | 13.21 Mn |
| Dec 31, 2022 | 14.91 Mn |
| Sep 30, 2022 | 17.40 Mn |
| Jun 30, 2022 | 19.09 Mn |
| Mar 31, 2022 | 20.02 Mn |
| Dec 31, 2021 | 18.19 Mn |
| Dec 31, 2020 | 539,597.00 |
API Access
Immix Biopharma Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=IMMX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "IMMX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=IMMX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();